Published in Ann Surg on August 01, 2003
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer (2004) 2.39
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg (2011) 1.45
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol (2006) 1.26
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer (2013) 1.25
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer (2005) 1.24
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer (2007) 1.21
Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients. Clin Exp Metastasis (2009) 1.11
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer (2012) 0.94
Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med (2011) 0.91
Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used? World J Surg (2009) 0.90
Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. HPB (Oxford) (2014) 0.89
Proposed follow up programme after curative resection for lower third oesophageal cancer. World J Surg Oncol (2010) 0.87
The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer (2006) 0.86
Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer. Neoplasia (2014) 0.84
Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy. Int J Clin Exp Med (2012) 0.83
A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther (2014) 0.82
Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2015) 0.81
Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett (2012) 0.80
The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis. Onco Targets Ther (2015) 0.80
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag (2015) 0.80
Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. Dig Dis Sci (2008) 0.78
Interleukin-8 producing hepatocellular carcinoma with pyrexia. HPB Surg (2009) 0.76
Time course of serum C-reactive protein levels during induction chemoradiotherapy and its correlation with treatment response and survival in patients with advanced esophageal squamous cell carcinoma. Mol Clin Oncol (2013) 0.76
Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig Dis Sci (2010) 0.75
Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers. Gastrointest Tumors (2016) 0.75
Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer. World J Surg (2017) 0.75
Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer. Dig Dis Sci (2008) 0.75
Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer. World J Surg (2017) 0.75
DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med (1965) 12.88
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi (1984) 3.02
Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer (1977) 2.65
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg (2001) 1.90
Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg (1994) 1.71
Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer (1999) 1.45
Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res (1996) 1.28
Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res (1996) 1.20
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer (1998) 1.04
Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg (2001) 1.04
Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg (2000) 1.02
Ultrasonic detection of lymph node metastases in the region around the celiac axis in esophageal and gastric cancer. J Clin Ultrasound (1985) 1.02
Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer (1999) 0.96
Ultrasonographic detection of lymph-node metastases in superficial carcinoma of the esophagus. Endoscopy (1996) 0.96
Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut (2000) 0.95
Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg (1999) 0.93
Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation. Cancer (1993) 0.93
Detection of androgen receptors in human esophageal cancer. Jpn J Surg (1989) 0.89
Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res (1995) 0.88
A new immuno quantitative method by latex agglutination--application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol (1986) 0.88
A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma. Dig Dis Sci (2001) 0.86
Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg (1996) 0.84
The oxidation of body fuel stores in cancer patients. Ann Surg (1986) 0.83
The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand (1982) 0.83
[Expression and significance of immunosuppressive acidic protein (IAP) in human esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi (1994) 0.81
Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res (2009) 2.61
Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell (2013) 2.23
Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res (2005) 2.05
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology (2006) 1.77
Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol (2011) 1.50
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med (2012) 1.47
Endosonographic detection of mediastinal lymph node metastasis in superficial carcinoma of the esophagus: assessment by type classification and histogram. J Gastroenterol (2004) 1.47
Delayed gastric emptying after pancreatoduodenectomy. J Surg Res (2011) 1.45
EGFR mutations and human papillomavirus in lung cancer. Lung Cancer (2012) 1.41
Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2002) 1.40
Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology (2008) 1.33
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg (2010) 1.32
Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res (2003) 1.30
Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res (2002) 1.29
A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery (2004) 1.29
Early experience of immediate reconstruction using autologous free dermal fat graft after breast conservational surgery. J Plast Reconstr Aesthet Surg (2006) 1.28
Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg (2005) 1.26
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery (2002) 1.24
Trans-Oral Video-Assisted Neck Surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach. Surg Endosc (2012) 1.22
Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 1.18
Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg (2008) 1.17
Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg (2006) 1.15
B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci (2011) 1.12
Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res (2002) 1.10
Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res (2009) 1.10
Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol (2011) 1.09
Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res (2004) 1.09
M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas (2013) 1.09
Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene (2002) 1.09
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg (2002) 1.08
The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases. Ann Surg Oncol (2014) 1.08
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer (2013) 1.08
Lymph node micrometastasis and lymphatic mapping determined by reverse transcriptase-polymerase chain reaction in pN0 gastric carcinoma. Surgery (2002) 1.06
Subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) prevents postoperative delayed gastric emptying. J Surg Oncol (2010) 1.06
Clinical and pathologic evaluation of implanted free dermal fat grafts after breast cancer surgery: a retrospective analysis. Surgery (2011) 1.06
Surgery for hepatocellular carcinoma located in the caudate lobe. World J Surg (2009) 1.06
Mesothelin expression correlates with prolonged patient survival in gastric cancer. J Surg Oncol (2011) 1.05
Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg (2006) 1.05
Immediate reconstruction using thoracodorsal adipofascial flap after partial mastectomy. Breast (2009) 1.04
Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res (2010) 1.04
Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum (2002) 1.04
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol (2002) 1.04
CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol (2009) 1.03
Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep (2007) 1.03
Immediate reconstruction using inframammary adipofascial flap of the anterior rectus sheath after partial mastectomy. Am J Surg (2007) 1.02
Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res (2007) 1.02
Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol (2005) 1.01
Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg (2011) 1.01
Immediate breast reconstruction using autologous free dermal fat grafts provides better cosmetic results for patients with upper inner cancerous lesions. Surg Today (2011) 1.01
Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis. Medicine (Baltimore) (2015) 1.00
Questionnaire survey regarding the current status and controversial issues concerning reconstruction after gastrectomy in Japan. Surg Today (2012) 1.00
Clinical implication of HLA class I expression in breast cancer. BMC Cancer (2011) 0.99
A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann Surg Oncol (2007) 0.99
Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial. Surg Today (2008) 0.99
Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer (2011) 0.99
Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy. Surg Today (2013) 0.98
Oncoplastic surgery combining partial mastectomy with breast reconstruction using a free nipple-areola graft for ductal carcinoma in situ in a ptotic breast: report of a case. Surg Today (2011) 0.98
Postoperative long-term evaluation of interposition reconstruction compared with Roux-en-Y after total gastrectomy in gastric cancer: prospective randomized controlled trial. Am J Surg (2011) 0.98
The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett (2003) 0.98
Current status of pylorus-preserving gastrectomy for the treatment of gastric cancer: a questionnaire survey and review of literatures. World J Surg (2012) 0.97
Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. J Surg Oncol (2008) 0.97
STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma. Ann Surg Oncol (2010) 0.97
Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol Cell Biol (2005) 0.97